Currently, Chromocell Therapeutics Corp.’s (CHRO) stock is trading at $0.71, marking a gain of 5.36% from last night’s close. At this price, the stock is -88.20% below its 52-week high of $6.00 and 36.15% above its 52-week low of $0.52. Based on the past 30-day period, the stock price is -35.41% below the high and +37.88% above the low.
How does Chromocell Therapeutics Corp. (CHRO) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Chromocell Therapeutics Corp. (AMEX: CHRO) Ownership Details
I will give a breakdown of the key shareholders in Chromocell Therapeutics Corp. (CHRO). Recent figures show that the company’s insiders hold 80.76% of shares. A total of 7 institutional investors hold shares in the company, making 9.43% of its stock and 49.00% of its float.
Jun 30, 2024, it was reported that the Company’s largest institutional holder is Anson Funds Management LP holding total of 201.03 shares that make 3.49% of the company’s total number of shares and are currently priced at 0.14 million.
The securities firm Citadel Advisors Llc holds 18.71 shares of CHRO, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.32%, and the holding percentage of shares is valued at 13285.0.
An overview of Chromocell Therapeutics Corp.’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Chromocell Therapeutics Corp. (CHRO) traded 264,503 shares per day, with a moving average of $0.6841 and price change of -0.3030. With the moving average of $0.7977 and a price change of -0.0712, about 146,641 shares changed hands on average over the past 50 days. Finally, CHRO’s 100-day average volume is 87,652 shares, alongside a moving average of $0.9946 and a price change of -0.6230.
